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A cDNA encoding a human endothelium-derived vasoconstrictor peptide, endothelin, was isolated from a human placen- 
ta cDNA library. The nucleotide sequence of this cDNA clone showed that the primary structure of the human preproen- 
dothelin has 212 amino acid residues and is highly homologous to porcine preproendothelin, and that human endothelin 
is identical with porcine endothelin. 
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1. INTRODUCTION 
We have recently purified and sequenced a 
21 -residue vasoconstrictor peptide derived from 
porcine endothelium which was named endothelin. 
This peptide does not belong to any reported pep- 
tide family. As it is one of the most potent vaso- 
constrictors and the expression of the endothelin 
gene is regulated by several vasoactive agents, the 
peptide may function as a messenger in a novel 
endothelium-mediated cardiovascular control 
system. Disturbances in the control of endothelin 
production and/or in the sensitivity of vascular 
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The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession number 
YO0749 
smooth muscle cells to endothelin might be a 
causative factor of hypertension and spastic 
disorders of blood vessels. As an initial step in in- 
vestigating the physiological, pathophysiological 
and possible clinical implications of endothelin in 
humans, we cloned preproendothelin cDNA from 
a human placenta cDNA library. Here we describe 
the amino acid sequence of human preproen- 
dothelin deduced from the cDNA sequence. 
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Fig. 1. Human endothelin precursor cDNA clones. Lines and 
boxes indicate the untranslated and coding regions, 
respectively. The sequences encoding mature endothelin are 
denoted by closed boxes. Restriction sites: AC, AccI; Av, Aval; 
B, EgflI; E, EcoRI; Hi, HindHI; Hp, HpaII; P, Pstl. 
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-252 -240 -210 -180 
CTGCGCCAGGCGAACGGGTCCTGCGCCTCCTGCAGTCCCAGCTCTCCACCGCCGCGTGCGCCTGCAGACGCTCCG -178 
-150 -120 -90 
CTCGCTGCCTTCTCTCCTGGCAGGCGC~GCCTTTTCTCCCCGTTAAAGGGCACTTGG~CTGAAGGATCGCTTTGAGATCTGAGGAACC~G 
-50 -30 -1 
CAGCGCTTTGAGGGACCTGAAGCTGT~TTTC_TTCGTTTTCCTTT~GGTT~AGTT~G-AA~GGGAGG~TTTTGATCC~--TTTTTTTCAG~ -- 
CATTTTTCTGCCTTT-TTCCCCCCGCTTTCGGTTTAGTTCGCAGGGGGAGGATTTTGATCCTTTTTTTTTTCAGA 
1 30 SO ?O 
ATGGATTATTTG_CTCATGATT~TC~CTCTGCTGTTTGTGGCTTGCCAAGGAGCTCCAGAAACAGC~GTC~T~GGCGC~GAGCTCAGC~CG 
MDY@@HI@@LLFVA~QGAP 
MDYFPMI I 
ETAVLGAELSG 
IALLFVAFOGAPETAVLGAELSP 
ATGGATTATTTCCCCATGATTATCGCTCTGCTGTTTGTGGCTTTCCAAGGAGCTCCAGAAACAGCGGTCCTGGGCGCCGAGCTCAGCCCG 
l?O ISO la0 
GTGGGTGAGAACGGCGGGGAGAAACCCACTCCC T~CACCCTGGC_GGCTCCG~CGGTCCAAGCGCTGCTCCTGCTC~TCCCTGATGGAT 
@-@R&-G E@PBP % @~WR~RRSKR 
EAESQGETPSPHASWRPRRSKR 
GAAGCCGAGAGCCAAGGGGAGACGCCCTCTCCCCATGCATCCTGGAGGCCCCGTCGGTCCAAGCGC 
240 240 
GTCAACACTCCC_CAG_CACGTTGT~CC~TA~GGACTTGGAAGCCCT---AGG 
VNTPEHDVPYGLGSP-R 
VNTPEHI VPYGLGSPSR 
AAAGAGTGTGTCTACTTCTGCCACCTGGACATCATCTGGGTCAACACTCCAGAACACATTGTCCCATACGGACTTGGAAGCCCTTCTAGG 
270 300 330 
TC~AAGAGAGCCTTGGAGAATTTACTTCCCAC~AAGGCAACAGACCGTGAGAATAGATGCCA~TGTGC~AGCCAAAAAGACAAGAAGTGC 
S m-R -@ L-@-@I L-Q P-a K A -@I D Rx-@ R C CI C A S Q K D K K C 
SRRSLKDLFPAKAADRRDRCQCASQKDKKC 
TCCAGGCGATCCTTAAAGGATTTGTTTCCTGCAAAGGCAGCAGACCGCAGGGATAGA~ 
360 390 420 
450 reo 5!0 
TCCAAGCTTGG~AA_AAGTGTATTTATCAGCAG~T~GTGAGAGGAAGAAAAAT~AGAAGAAGTTCAGAGGAACACCTAAGACAAACCAGG 
SKLG@KCI~@PLV@GRKI RR- 
SKLGEKCIHROLVHGRKIRR---------- 
TCCAAGCTTGGAGAGAAGTGTATTCATCGGCAGCTGGTGATGGGAAGAAAAATAAGAAGG------------------------------ 
540 570 500 
TCGGAGACCATGAGAAACAGCGTCAAATCAAAlJZATCTTTTCA 
@E-(jj@@N S@K@S F H 
GATCCCAAGCTGAAAGGCAAGCCCTCCAGAGAGCG TATGTGACCCAC_AC 
%-@KLK@-@@@R@#@- V T H N 
LEA I SNSIKTSFHI AKLKAELYRDKKVTHN 
TTGGAGGCCATCAGCAACAGCATCAAAACATCTTTTCACATCGCCAAGCTGAAAGCCGAGCTCTACAGAGATAAGAAAGTGACCCATAAC 
530 560 590 
CGAG_CACA~TGG_TGACAG~T-~C~G~GCCTGTCTGAAGCCAT~CC_TCC~CG_G~GAGCCC_TGIG~CCGACTCTGC~CT--CTCCACCCT 
R@H@* 
R T H * * 
CGAACACACTGATGACAGGTTGGCCGAGCCTGTCTGAAGCCATCTCGTCCCCAGGGAGCCCCGGGCCCGACTCTGCGCTCGCTTGGCAGG 
7?0 750 7c)o 
GGCTG~GATCAGAGCAG~AGC~TCCTCTG~T-----~GTTCCT-------GACTGGCA~AGGACCAGC~CCTCG~C~AACATTCCA~ 
GGCTGAGATCAGAGCAGAAGCCTCCTCTGTTCAGACCGTTCCTTACTGCAGACTGGCACAGGACCAGCACCCTCG-CCTGAACATTCCAG 
S!O 840 fl?O 
_GAAAGG-TTAAGGAGT~CCCCCA~CCA-TCTTCA~TGGC~TCCATCAGTG~TAA~GC~GTCT~T~CT~TC~TC--T~G~G~TGA~ 
AAAAGGCTTAAGGAGTCCCCCCAGCCGGTCTTCATTGGCCTCCATCAGTGCTAAGCGCGGCCGTCTGT-CTCTCCTCCTTTGCGGTGATG 
900 9!5 
ATGG,$ClCTC&CAGAAA-CA~A~AG~CACATTCCAATC 
ATGGGCCACTCGA-AGAAAGCAGAGAGAGACA--CGGATGC--c 837 bp )--AATAAA--( 15 bp )--AAAAAAAAAAAAAAAA 
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Fig.2. Comparison ofnucleotide and deduced amino acid sequences of human and porcine preproendothelin precursor [l]. Base and 
amino acid substitutions are underlined and circled, respectively. Gaps, denoted by dashes, are introduced for maximal alignment. 
Amino acid residues corresponding to the mature endothelin and ‘endothelin-like’ segments are indicated by stippled and open boxes, 
respectively. The arrow shows the possible cleavage site of the signal peptide. 
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2. MATERIALS AND METHODS 
2.1. Oligonucleotide probe 
An oligonucleotide 5’-TGGCAGAAGTAGACGCACTC- 
CTTGTCCAT-3 ’ , containing the coding sequence for Met’- 
HisI of the porcine ndothelin [1], was chemically synthesized 
using a DNA synthesizer, model 380B (Applied Biosystems). 
This oligonucleotide was labeled to a specific activity of 5 x 
10s cpm/pg with Tq polynucleotide kinase in the presence of 
[y-‘*P]ATP (3000 Ci/mmol; Amersham). 
2.2. cDNA cloning 
A Xgtll human placenta cDNA library (Clontech Labora- 
tories, Inc.) was screened by plaque hybridization [2] with the 
synthetic probe. Hybridization was carried out in hybridization 
buffer-S [3] at 45’C for 16 h. The filters were washed once with 
2 X SSC (1 X SSC = 150 mM NaCl/lS mM Na citrate) at 45°C 
for 30 min and then twice with the same solution at 40°C for 
30 min. The filters were then dried and autoradiographed onto 
Kodak X-AR film at -40°C with intensifying screens. 
2.3. DNA sequence analysis 
Nucleotide sequence analysis was carried out by the dideoxy 
chain-termination method [4] using restriction fragments 
subcloned in Ml3 mp18 and mp19. 
2.4. Northern blot analysis 
Venous endothelial cells were obtained from a fresh human 
umbilical cord and cultured in monolayers as described [5]. Ex- 
traction of poly(A)+ RNA and Northern blotting were,perform- 
ed as described [l]. The random-prime-labeled pHET4-3 insert 
(5 x lo8 cpm/pg) was used as a probe. 
3. RESULTS 
3.1. cDNA cloning of human preproendothelin 
Two hybridization-positive plaques were iso- 
lated by the screening of approx. 8 x 10’ plaques 
from a human placenta cDNA library, and the in- 
serts were subcloned into the EcoRI site of plasmid 
pUC18. The plasmids, designated pHET4-2 and 
pHET4-3, have cDNA inserts of about 0.9 and 
1.17 kb, respectively (fig. 1). The EcoRI site in the 
3 ‘-untranslated region was considered to exist en- 
dogenously, since the EcoRI-flanking sequences of 
pHET4-2 and pHET4-3 were identical. Further- 
more, this EcoRI site was shown to exist also in 
human preproendothelin gene (unpublished). Fig.2 
shows the complete nucleotide sequence of the 
pHET4-3 insert and the deduced amino acid se- 
quence aligned with the porcine sequences [l]. The 
nucleotide sequence contained only one long open- 
reading frame from the 5 ‘-proximal ATG codon. 
This initiation codon is within the consensus se- 
quence established for eukaryotic translation in- 
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itiation sites [6]. Furthermore, the encoded amino 
acid sequence CysS3-Trp73 was identical to the 
porcine endothelin sequence. We concluded from 
these results that pHET4-3 contains the complete 
coding region of human endothelin precursor. 
Northern analysis showed that a single 
2.2-2.3 kb preproendothelin mRNA was express- 
ed in cultured human umbilical vein endothelial 
cells (fig.3). Assuming that the poly(A) tail is -200 
bases long and the length of the 3 ‘-noncoding 
region is comparable to that of the porcine mRNA, 
it follows that the 5 ‘-end of the pHET4-3 insert is 
very close (within -50 bases) to the cap site of the 
mRNA. 
3.2. Structural characteristics 
The predicted human preproendothelin had 212 
amino acid residues and was 69% homologous 
with porcine preproendothelin (fig.2). The se- 
quence differences included both substitutions and 
insertions/deletions. Out of 55 substitutions, 25 
2as- 
la+ 
Fig.3. RNA blot hybridization analysis. Positions of human 
ribosomal RNAs (28 S and 18 S) are indicated. 
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residues were conservative substitutions [7]. The 
hydrophobicity profile is, as expected, very similar 
to that of the porcine precursor (fig.4). Although 
we have not sequenced human endothelin at the 
peptide level, human mature endothelin is very 
likely the 21-residue peptide from CYSTS to Trp73, 
since the sequence between Arg4* and His79, which 
includes the porcine endothelin sequence, is 
perfectly conserved in human and porcine pre- 
cursors. In addition to endothelin, the precursor 
has a cysteine-rich endothelin-like segment 
(Cys’09 -CYS’~~). This region is also particularly 
conserved when compared with the porcine precur- 
sor, although the role of this segment is presently 
unknown. 
The nucleotide sequence is also highly con- 
served, and the homology in the coding regions is 
79%. It is particularly noteworthy that the 5 ’ - and 
3 ’ -noncoding regions are also significantly con- 
served (7 1% and 75 %, respectively), suggesting the 
functional importance of these regions, e.g., for 
the regulation of mRNA stability. 
I ndex 
4. DISCUSSION 
Endothelin and its cDNA were originally iso- 
lated from porcine aortic endothelial cells, and we 
have succeeded in obtaining a human endothelin 
cDNA from a placenta cDNA library. The 
presence of preproendothelin mRNA in the placen- 
ta was probably due to the high vascularity of this 
tissue. The predicted amino acid sequence of 
human mature endothelin did not differ from that 
of porcine endothelin. This seems to suggest hat 
the preproendothelin gene has evolved under 
strong pressure to conserve the structure, and 
hence the function, of the mature peptide. 
A possible cleavage site of the signal peptide was 
located after Gly”, based on a weight-matrix ap- 
proach [8]. After removal of the signal peptide, the 
22478 Da putative proendothelin might be pro- 
cessed to a 2492 Da mature endothelin in a manner 
similar to that for porcine endothelin, namely, 
through NH2-terminal processing at the dibasic- 
pair Lys” -ArgS2 and an unusual COOH-terminal 
0 E;fi 120 180 2740 
Fig.4. Hydrophobicity index along the amino acid sequence of human and porcine endothelin precursors. The hydrophobicity values 
were calculated with the hexapeptide averaging method [9]. The positions of endothelin sequences are underlined. 
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processing between Trp73 and Va174. The expres- REFERENCES 
April 1988 
sion of human preproendothelin cDNA in recom- 
binant mammalian cells would facilitate the 
characterization of this previously unknown type 
of peptide processing. 
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